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Abstract
Genetic and genome-wide RNAi approaches available in C. elegans, combined with tools for visualizing subcellular events
with high-resolution, have led to increasing adoption of the early C. elegans embryo as a model for mechanistic and
functional genomic analysis of cellular processes. However, a limitation of this system has been the impermeability of the
embryo eggshell, which has prevented the routine use of small molecule inhibitors. Here, we present a method to
permeabilize and immobilize embryos for acute inhibitor treatment in conjunction with live imaging. To identify a means to
permeabilize the eggshell, we used a dye uptake assay to screen a set of 310 candidate genes defined by a combination of
bioinformatic criteria. This screen identified 20 genes whose inhibition resulted in .75% eggshell permeability, and 3 that
permeabilized embryos with minimal deleterious effects on embryo production and early embryonic development. To
mount permeabilized embryos for acute drug addition in conjunction with live imaging, we combined optimized inhibition
of one of these genes with the use of a microfabricated chamber that we designed. We demonstrate that these two
developments enable the temporally controlled introduction of inhibitors for mechanistic studies. This method should also
open new avenues of investigation by allowing profiling and specificity-testing of inhibitors through comparison with
genome-wide phenotypic datasets.
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Introduction
Small molecule inhibitors are a valuable tool for the analysis of
fundamental cellular functions and an entry point for the
development of therapeutic agents. In mechanistic studies, the
primary advantage of small molecules is temporal control, which is
especially powerful when combined with live imaging. Drug
delivery experiments are straightforward in tissue culture cells,
where drugs can simply be added to the medium. However, in C.
elegans embryos, where RNA-interference (RNAi)-based analysis has
generated extensive phenotypic datasets and provided fundamental
insights into many cellular processes, use of small molecule
inhibitors has been limited due to eggshell impermeability.
Laser puncturing [1] or pressure against an overlying coverslip
[2] have been used to permeabilize the C. elegans eggshell for drug
delivery, but both techniques have significant drawbacks that
preclude their routine use. Laser puncturing requires a sophisti-
cated setup and confines drug entry to a single narrow opening,
which leads to slow and spatially non-uniform introduction of
inhibitors into the embryo. The compression method is prone to
disrupt embryonic processes and is difficult to control. Eggshells
have also been weakened in bleach followed by chitinase treatment
and passing the embryos through a narrow mouth pipette [3];
however, this method often ruptures embryos and is difficult to
execute consistently.
Here, we present a simple method for generating uniformly
permeable C. elegans embryos and immobilizing them to allow
acute drug treatment with simultaneous live imaging. To identify a
means to permeabilize embryos, we performed an RNAi-based
screen of a set of 310 candidate genes. This screen identified 3
genes whose inhibition yielded penetrant embryo permeability
with minimal deleterious effects on embryo production and early
embryonic development. To mount permeabilized embryos for
acute drug addition in conjunction with live imaging, we
combined optimized inhibition of one of these genes with the
use of a microfabricated chamber that we designed. We
demonstrate the efficacy of this method by treating embryos with
three different small molecule inhibitors.
Results and Discussion
To identify an RNAi-based means to permeabilize the C. elegans
eggshell to allow introduction of small molecule inhibitors while
maintaining normal progression through the early embryonic cell
divisions, we screened through a collection of 310 candidate genes,
chosen based on their primary sequence features and/or
phenotypic profiles (Fig. 1A; see Spreadsheet S1.xlsx for candidate
gene selection details). Worms were soaked in dsRNA targeting
each candidate gene and placed onto plates containing the dye
Nile Blue A; dye uptake into the embryos indicates eggshell
permeability (Fig. 1B) [4]. This screen identified 51 genes whose
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resulted in .75% embryo permeability. Penetrant (.75%)
embryo permeability combined with a normal brood size was
observed for 10 genes (Fig. 1C; Table 1; for a complete screen
summary see Spreadsheet S1.xlsx); four of these genes were
previously uncharacterized, and we named them dgtr-1 (DGAT-
related), egg-6 (EGG sterile), perm-1 and perm-2 (for PERMeable
eggshell). Sequence comparisons suggested that dgtr-1 is related to
the DGAT/MGAT family of enzymes and is likely to be involved
in lipid synthesis. Of these 10 genes, inhibition of 7 had previously
been shown to lead to defects in gonad structure [5] or to
disruption of events in the early embryo [6,7,8,9,10]. Inhibition of
the remaining three genes (dgtr-1, perm-1, and ptr-2) resulted in
minimal deleterious effects on embryo production and on early
embryonic development. We selected perm-1 (T01H3.4), for
additional optimization. Partial inhibition of perm-1 gave rise to
embryos permeable to the lipophilic dye FM4-64 (Fig. 2A) that
progressed through the early embryonic cell divisions with normal
timing (Fig. 2B). Embryos permeabilized by perm-1 inhibition did
exhibit late embryonic lethality; however, this has also been
observed following permeabilization via other means [3,11,12]
and may reflect a requirement for an impermeable eggshell to
properly execute morphogenetic events during later embryonic
development. Thus, as with other permeabilization methods, perm-
1(RNAi) allows access to events during the early embryonic cell
divisions.
perm-1(RNAi) can be performed by soaking, feeding or injection.
For all delivery methods, we were able to optimize RNAi
conditions to obtain ,80–100% permeable embryos with no
discernable defects during the first two embryonic divisions (Figs.
S1, S2). The major defect encountered when perm-1(RNAi)
conditions are not properly titrated is resorption of the second
polar body. Soaking and feeding are the easiest delivery methods,
but we have found injection to be the most effective when
combining perm-1(RNAi) with RNAi of other targets (perm-1
dsRNA is effective when mixed with a second dsRNA at a ratio
of 1 to 6; data not shown).
We next developed a method to combine perm-1(RNAi)-
mediated permeabilization with live imaging in a manner that
facilitates small molecule addition. For this purpose, the
permeabilized embryos needed to be stably mounted during
medium exchange. Permeable embryos are more fragile than
embryos with an intact eggshell and cannot be compressed under a
coverslip or transferred using mouth pipettes. We therefore
designed a microdevice that allows the in-situ dissection of adult
hermaphrodites and immobilization of the released permeable
embryos for imaging before and after small molecule addition
(Fig. 3). The device consists of a microfabricated composite chip,
which is made of silicone elastomer and epoxy, and a #1.5,
24660 mm coverslip, which is attached to the bottom of the chip.
The chip has a rectangular well that has an elevated hard epoxy
dissection board on the bottom on one side and an 866.4 mm
array of 16 microwells on the other (Fig. 3A,B and S3). In the
beginning of an experiment, the well and the microwells are filled
with osmotic support medium and a worm is placed on the
dissection board. The worm is cut open with a scalpel, and an
eyelash tool is used to move the released permeable embryos into
the microwells, where they rest on the coverslip surface facilitating
imaging with an inverted microscope (Fig. 3C). At the desired time
of drug addition, the medium in the well is replaced with medium
containing the drug of interest. A single cycle of aspiration/
dispensing leads to an equilibrium small molecule concentration in
the well that is ,60% of that in the added buffer. Equilibrium with
the buffer in the microwells is achieved within ,5 seconds and the
embryos remain motionless during the entire process of buffer
exchange (Fig. S3B).
To confirm that combining perm-1(RNAi) with use of the
microdevice enables routine small molecule-based experiments in
C. elegans embryos, we performed treatments with three different
inhibitors: the microtubule depolymerizing agent nocodazole, the
actin inhibitor latrunculin A, and the proteasome inhibitor c-
lactocystin-ß-lactone. All 3 inhibitors had the expected effects:
nocodazole caused rapid spindle collapse if added after nuclear
envelope breakdown (NEBD; Fig. 4B,C; yellow asterisk marks
frame when drug was added, Movie S1). If nocodazole was added
earlier, it prevented pronuclear migration; if added just after
anaphase onset, it inhibited cytokinesis (Fig. 4D, Movies S2 and
S3). Addition of latrunculin A before furrow ingression blocked
cytokinesis but not nuclear division (Fig. 4F, Movie S4). The
proteasome inhibitor, c-lactocystin-ß-lactone, caused a metaphase
arrest when added early (meiosis II, ,25 minutes prior to
metaphase, Movie S5); if added just before mitosis (at NEBD), it
delayed the metaphase-anaphase transition but did not cause a
metaphase arrest until the subsequent cell cycle (Fig. 4E, Movie
S6). Addition of the same inhibitors had no effects on control
impermeable embryos. These results establish that perm-1(RNAi)
and the microdevice can be used to combine precisely controlled
inhibitor treatments with dynamic imaging of the early C. elegans
embryo.
We describe a robust method that overcomes the impermeabil-
ity of C. elegans embryos to allow small molecule inhibitor studies in
this widely utilized experimental model. This method enables
precisely timed inhibitions, which will greatly enhance ongoing
studies of cell division, cell polarity, nuclear membrane assembly/
disassembly, membrane trafficking, and cortical dynamics. Com-
bining our method with mutants/RNAi will provide a means for
testing inhibitor specificity in an in vivo context. We anticipate that
the precise phenotypic profiling possible in the early C. elegans
embryo will also aid in target identification for inhibitors
discovered in cell-based screens, given the richness of functional
genomic datasets available in this system. Although the micro-
device we describe here is optimized for treatment of embryos
from a single strain with a single inhibitor, we anticipate that
devices with similar designs could allow more high-throughput
screening of multiple strains and/or inhibitors.
Materials and Methods
Selection of candidate genes for eggshell permeability
screen
All candidate genes encode secreted or membrane-associated
proteins as judged by the presence of a signal peptide or a
predicted transmembrane or signal anchor domain (SignalP 3.0,
www.cbs.dtu.dk/services/SignalP; PSORT II, psort.hgc.jp/
form2.html) and were selected from a curated list of C. elegans
secreted proteins provided by Brian Ackley and Andrew
Chisholm. For the majority of candidates, we also required at
least one line of prior evidence for a role in the germline. Our
candidate gene set included all of the germline enriched [13,14]
and maternal sterile genes [5] that had a signal peptide. Since the
set of genes previously found to be expressed in dissected germlines
that have a signal peptide is large (Serial Analysis of Gene
Expression database, Genome BC C. elegans Gene Expression
Consortium, http://elegans.bcgsc.bc.ca), germline expressed
genes were only included if they had previously been shown to
result in embryonic lethality when inhibited by RNAi (Wormbase
release WS199). Genes with domains found in proteins previously
implicated in the formation of extra-embryonic layers (chitin
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LDLR domains; Wormbase release WS202) were included
regardless of whether there was prior evidence for a germline
role. Due to redundancy, the total number of candidate genes was
310 (see Spreadsheet S1.xlsx for a breakdown of genes by
identification method).
Eggshell permeability screen
Oligo design, PCR, RNA transcription and annealing, and
soaking RNAi were performed as described in Ref. [5]. The
primer pairs used to amplify 500–1000 bp target regions of
candidate genes are listed in Spreadsheet S1. For RNAi
experiments, five to seven L4 stage larval worms were soaked in
dsRNA (or soaking buffer for control experiments) for 24 hr at
20uC and recovered individually to NGM plates containing
150 mg/ml Nile Blue A, which penetrates permeable, but not
intact, eggshells [4]. dsRNA-treated adults were allowed to lay
embryos for 24 hr at 25uC (Plate 1), then transferred to a fresh
plate to lay embryos for an additional 24 hr (Plate 2). One day
after the adult was removed, the number of hatched larvae,
impermeable embryos (clear), and permeable embryos (blue) were
counted for each plate, the sum of which was recorded as brood
size. Averages for the 5–7 worms are reported (Spreadsheet
S1.xlsx). A maximum of 50 hatched larvae per plate were counted.
Control worm plates normally contained 0–4% permeable
embryos.
Soaking or Feeding RNAi, transfer to chamber, addition
of small molecules
To generate the permeable embryos in Figs. 2 and 4, dsRNA
against T01H3.4 was prepared by using the oligos in parentheses
(taatacgactcactataggAATTTTCTAGGTCGTCAATCTTCA, aa-
ttaaccctcactaaaggCGAAAACGCGATCATTTTTA) to amplify
the corresponding region from N2 genomic DNA. The PCR
reaction was cleaned (Qiagen, Valencia, CA) and used as template
for 50 ml T3 and T7 transcription reactions (Ambion, Austin, TX).
The two reactions were cleaned (MEGAclear kit, Ambion, Applied
Biosystems), eluted with 50 ml of DEPC-treated H2O each,
combined and mixed with 50 mlo f3 6 soaking buffer (32.7 mM
Na2HPO4, 16.5 mM KH2PO4, 6.3 mM NaCl, 14.1 mM NH4Cl).
The RNA was annealed by incubating the mix at 68uC for
10 minutes followed by 37uC for 30 minutes and then frozen down
in aliquots. RNAi was performed by placing 20–25 L4-stage worms
(strains listed in Table S1) in a drop of 5 ml of dsRNA, after adding
0.25 ml 63 mM spermidineand 0.25 ml 1.1% gelatin, on parafilm in
a humidchamberat20uC.After4 hours,wormsweretransferredto
a seeded NGM (nematode growth medium) plate and incubated for
16–22 hours at 16uC.
Figure 1. A screen for genes required for eggshell impermeability. A. Since the eggshell is a secreted structure, all candidate genes encoded
proteins with a signal peptide or a membrane-targeting domain. Our candidate gene set included all of the germline enriched ([13,14]) and maternal
sterile ([5]) genes that have a signal peptide. Since the set of genes expressed in dissected germlines that have a signal peptide is large (1137 genes,
Serial Analysis of Gene Expression database, Genome BC C. elegans Gene Expression Consortium, http://elegans.bcgsc.bc.ca) we included only those
previously shown to result in embryonic lethality when inhibited by RNAi (Wormbase release WS199). Genes with proteins domains (chitin binding,
glycosylation, protease, peroxidase, lipid binding, or LDLR domains) found in proteins implicated in eggshell formation or analogous processes in
other species were included regardless of whether there was prior evidence for a germline role. Due to redundancy, the total number of candidate
genes was 310. B. Outline of screen to identify genes specifically required for eggshell impermeability. C. Of the 310 candidate genes tested, 3 genes
were identified whose inhibition permeabilized the eggshell with high penetrance (.75% permeable embryos), while maintaining a normal
broodsize and leading to minimal defects in gonad structure/embryonic development. One of these genes, perm-1, was chosen for further
optimization.
doi:10.1371/journal.pone.0024656.g001
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library [15] was used. Bacteria expressing dsRNA targeting
T01H3.4 were grown overnight at 37uC in LB with 100 mg/ml
ampicillin. The overnight culture was diluted 1:50 in LB with
100 mg/ml ampicillin and grown at 37uC until culture reached an
OD600 between 0.4–0.7 (,2.5 hours). The bacterial culture
(,200 ml/plate) was spread onto 6 cm NGM agar plates
containing 0.01 mM IPTG. Plates were dried in a sterile hood
for ,1 hour and left at room temperature for ,4 hours to induce
RNA expression. 30–50 L4 or young adult stage worms were
transferred onto each plate and incubated overnight at 20uC for
14–20 hours.
For imaging, the microdevice well was filled with ,75 ml 0.7X
Egg Salts (1X Egg Salts: 118 mM NaCl, 40 mM KCl, 3.4 mM
MgCl2, 3.4 mM CaCl2, 5 mM HEPES pH 7.4), 1–3 worms were
placed on the dissection board, cut open with a scalpel, and the
one-cell embryos were swept towards the wells using an eyelash
tool. The microdevice was placed on a metal slide with an opening
at the location of the well, the slide was fastened to the microscope
stage, and time-lapse imaging was initiated. When the embryos
reached the desired stage, the medium in the well was exchanged
by using a syringe with a blunt-end needle to remove the existing
medium and adding fresh medium supplemented with the drug of
interest with a pipette. Drugs used: 10 mg/ml nocodazole (Sigma,
# M1404), 10 mM Latrunculin A (Sigma, # L5163), and 20 mM
c-lactocystin-ß-lactone (Calbiochem, # 426102). At the end of
each experiment, medium containing 33 mM FM4-64 (Molecular
Probes, # T13320) was added to the well to confirm that the
imaged embryo was permeable.
Live imaging
Embryos were imaged at 21uC using a 606 1.4 NA
PlanApochromat lens on a spinning disk confocal setup mounted
on a Nikon TE2000-E inverted microscope equipped with a solid-
state laser combiner (ALC) – 491 nm and 561 nm lines – a
Yokogawa CSU10 head and a CCD Clara camera (Andor
Technology). Acquisition parameters, shutters, and focus were
controlled by iQ 1.10.0 software (Andor Technology). Exposure
times were 200 miliseconds for microtubules, DNA and plasma
membrane GFP-labeled probes (laser power=100 mW), and 400
miliseconds for the mCherry-labeled histone (laser
power=100 mW). Imaging conditions were 562 mm GFP/RFP
z-series every 20 seconds. Analysis of acquired images was
performed with MetaMorph software (Molecular Devices, Down-
ington, PA).
Microdevice fabrication
The microdevice (Fig. 3 and S3) consisted of a composite chip
attached to a 24660 mm #1.5 microscope coverslip. The
composite chip was assembled from three parts: 1) a rectangular
14616 mm, 3 mm thick polydimethylsiloxane (PDMS, Sylgard
184 by Dow Corning) chip with a rectangular 866.4 mm opening
in the middle and a 6610 mm, 250 mm deep counter-groove on
its bottom; 2) a 6610 mm, 200 mm thick plate micro-machined of
a UV-curable epoxy that was inserted into the groove in the
PDMS chip (dissection board); and 3) a 14616 mm, 150 mm thick
layer of PDMS with an array of 16 square 3006300 mm through-
holes arranged in two rows, with a 700 mm distance between
adjacent holes in a row and a 800 mm distance between the rows
(array of microwells).
The 3 mm PDMS chips were cast using a master mold made of
a resin (clear PolyJet FC720) on a high-resolution solid printer
(PolyJet
TM with an x-y-z resolution of 600-300-1600 dpi; Redeye,
Eden Prairie, MN). A single cast made by baking PDMS on the
mold in an 80uC oven for 90 min produced 12 individual chips.
The high z-axis resolution of the mold (,16 mm) was essential to
generate counter-grooves with the depth closely matching the
thickness of the epoxy plates (250 vs. 200 mm). To make the epoxy
plates, a 5 inch silicon wafer was treated with trimethylchlorosilane
(TMCS) to passivate its surface, a 200 layer of the UV-curable
epoxy (SU8 2100 by MicroChem, Newton, MA) was spin-coated
onto the wafer, pre-baked on a hot-plate, exposed to UV-light
through a specially designed photomask, post-exposure baked, and
developed. In the areas exposed to the UV light, cross-linked
epoxy plates were formed. The plates were separated from the
wafer and inserted into the grooves on the bottom surfaces of the
PDMS chips.
To make the 150 mm thick perforated layer of PDMS, another 5
inch silicon wafer was spin-coated with SU8 2100 epoxy, which
was exposed through another photo-mask and developed (with
appropriate pre-baking and post-baking) to produce a relief with
12 separate arrays of 300 mm tall, 3006300 mm posts on the wafer
surface. The wafer was then spin-coated with an ,150 mm thick
layer of PDMS pre-polymer, so that the top surfaces of the posts
were exposed (PDMS free) [16]. The wafer was placed on a
leveled plate in a 65uC oven for 7 min to let the pre-polymer
reflow and partially cure. The PDMS chips with inserted epoxy
Figure 2. perm-1 inhibition permeabilizes the eggshell without
altering cell division timing. A. Schematics and confocal images of
impermeable (no RNAi) and permeable (perm-1(RNAi)) embryos co-
expressing GFP-histone H2B and GFP-alpha-tubulin. Embryos at meta-
phase of the first mitotic division were submerged in media containing
the lipophilic dyeFM4-64, which passesthrough the eggshell to label the
plasma membrane of permeable (right), but not impermeable (left)
embryos. Scale bar, 10 mm. B. Time intervals between NEBD and
metaphase, metaphase and anaphase, and anaphase and cytokinesis
onset were measured for permeable embryos (perm-1(RNAi)); red bars)
and impermeable wild-type controls (green bars).
doi:10.1371/journal.pone.0024656.g002
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posts on the wafer, and the wafer with the PDMS chips was baked
in an 80uC oven to completely cure the 150 mm PDMS layer and
permanently bond the chips to it. The PDMS layer was then cut
around the edges of the 3 mm PDMS chips, and the composite
chips with the epoxy plates and perforated PDMS membranes at
the bottom were carefully separated from the wafer. To complete
the microdevices, the bottom sides of the composite chips were
reversibly bonded to coverslips.
In a complete microdevice, the 3006300 mm through-holes in
the 150 mm PDMS layer formed microwells for immobilization of
C. elegans embryos, the epoxy plate formed an integrated dissection
board for adult C. elegans hermaphrodites, and the 866.4 mm
opening in the 3 mm PDMS chip formed a macroscopic well for
culture medium. To facilitate loading of medium into the
microwells, microdevices were treated with air plasma (Plasma-
Preen II by Plasmatic Systems Inc.) for 5 seconds to make the
PDMS and glass surfaces hydrophilic.
Table 1. Screen hits (.75% permeable embryos & brood size* .90).
Target ORF Gene name Gene description NCBI KOG Human homolog
Lipid biosynthesis, modification, or sensing
F32H2.5 fasn-1 Fatty Acid SyNthase None FASN (NP_004095.4)
H02I12.8/
Y17G9B.3
cyp-31A2/3 CYtochrome P450 family Cytochrome P450 CYP4/CYP19/
CYP26 subfamilies
CYP4V2 (NP_997235.3)
K10D2.6 emb-8 Cytochrome P450 NADPH-reductase NADP/FAD dependent
oxidoreductase
POR (NP_000932.3)
W01A11.2 dgtr-1 (DGAT-Related); putative Acyl-CoA:diacylglycerol
acyltransferase
Acyl-CoA:diacylglycerol
acyltransferase
Related to enzymes in the DGAT/MGAT
family
C32E8.8 ptr-2 PaTched Related Patched superfamily PTCHD family
Glycosylation, chitin-binding
C07G2.1/B0280.5 cpg-1/cpg-2 Chondroitin ProteoGlycan None None
Meiosis/Mitosis
T05G5.7 rmd-1 Regulator of Microtubule Dynamics Uncharacterized conserved protein Unclear
Uncharacterized
T01H3.4 perm-1 PERMeable eggshell None None
K07A12.2 egg-6 EGG sterile Leucine rich repeat None
C44B12.1 perm-2 PERMeable eggshell None None
*Brood size=total number of hatched larvae, permeable embryos, and dead embryos on the Day1 and Day2 plates combined.
doi:10.1371/journal.pone.0024656.t001
Figure 3. A microdevice that immobilizes permeable embryos for simultaneous imaging and small molecule addition. A. Photograph
of the microdevice. B. Schematic drawings of the top and side views of the microdevice. C. Schematic depicting the procedure for preparing
permeabilized embryos for drug treatment and imaging. C. elegans hermaphrodites at the L4 larval stage are soaked in a drop of perm-1 dsRNA for
4 hours at 20uC. The worms are transferred to a plate with bacteria and allowed to recover for 16 hours at 16uC. 1–3 worms are placed on the
dissection board of the microdevice after filling it with ,100 ml of media. Worms are dissected with a scalpel and the released early embryos are
swept into the microwells with an eyelash tool. The microdevice is transferred to the microscope and the embryos are imaged. When the desired
stage is reached, the medium in the microdevice is replaced with fresh medium containing the drug of interest.
doi:10.1371/journal.pone.0024656.g003
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To test medium exchange, the medium in the microwells was
exchanged by consecutive steps of aspiration from the 866.4 mm
well with a 200 ml pipette and dispensing new medium into the
well. During this process, the pipette tips never touched the
microdevice, which limited the degree of medium exchange in a
single aspiration/dispensing step. To estimate the time required
for the small molecule concentration in the microwells to
equilibrate with that in the well and to measure the eventual
small molecule concentration in the microwells, we filled the well
with a 60 ppm (by weight) solution of fluorescein (molecular
weight ,376 Da, coefficient of diffusion D<4.5610
26 cm
2/s) in
Figure 4. Acute drug treatments with nocodazole, latrunculin A, and c-lactocystin-ß-lactone. A. Schematics illustrating the stages
between anaphase meiosis II and cytokinesis of the first mitotic division following fertilization. Red numbers mark the timepoints highlighted in the
panels in B, D, E and F. B. Confocal images of permeable embryos expressing GFP-histone H2B and GFP-alpha-tubulin. A control embryo (left) and an
embryo treated with 10 mg/ml nocodazole after NEBD (right) are shown. Addition of nocodazole results in rapid microtubule depolymerization.
Numbers in white indicate time in seconds after NEBD. Scale bar, 5 mm. C. Mean pole-to-pole distance plotted versus time for the indicated
conditions. Embryos treated with nocodazole after NEBD exhibit a rapid reduction in pole-to-pole distance due to microtubule depolymerization.
Error bars are the 95% C.I. of the mean. D. Images of permeable embryos expressing GFP-histone and GFP-alpha-tubulin. Nocodazole was added
during pronuclear migration (left) or in early anaphase (right). In both cases, rapid microtubule depolymerization was observed. Scale bar, 10 mm.
Numbers in white indicate time in seconds after the timepoint when drug was added. E. Images of permeable embryos expressing GFP-histone H2B
and GFP-alpha-tubulin. The proteasome inhibitor, c-lactocystin-ß-lactone (20 mM) was added either early (anaphase of meiosis II; left) or just before
NEBD (right). If added early, the embryo arrested at the first metaphase. If added before NEBD, the metaphase-anaphase transition was delayed, but
the embryo did not arrest until metaphase of the second division. Scale bar, 5 mm. Numbers in white indicate time in seconds after NEBD of the first
mitotic division. F. Images of embryos expressing a GFP-labeled plasma membrane probe and RFP
mCherry-histone H2B. Latrunculin A (10 mM) added
after anaphase onset prevented cleavage furrow ingression. Scale bar, 10 mm. Numbers in white indicate time in seconds after anaphase onset.
Yellow asterisks in the upper left corner of the panels in B, D, E and F mark the time point when drug was added.
doi:10.1371/journal.pone.0024656.g004
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microwells with a video-microscopy setup consisting of an inverted
fluorescence microscope (Nikon Diaphot) with a 606 1.2 NA
water immersion objective, 0.426video coupler, and Sony XCD-
X700 digital camera. The fluorescence illumination was derived
from a 455 nm LED driven by a stabilized power supply. We used
low illumination intensity in combination with a large exposure
time (0.2 seconds) and binning over a 50650 pixel region to
minimize photobleaching. The microscope was focused ,50 mm
above the glass surface in one of the 3006300 mm microwells,
corresponding to the approximate position of an embryo. Because
of the high numerical aperture of the objective (1.2), the
fluorescent signal was collected from a relatively thin layer around
the focal plane, and the initial concentration of 60 ppm was
sufficiently low to make the fluorescent signal proportional to the
current fluorescein concentration as fluorescein was diluted from
the microwell. Therefore, after subtraction of the background and
normalization to the initial level, the fluorescence signal was
representative of the fluorescein concentration normalized to its
initial value (60 ppm solution).
Dependence of the normalized fluorescein concentration on
time was recorded during 5 consecutive steps of aspiration of the
medium from the well and dispensing plain buffer into the well
(Fig. S3B). The time dependence showed that each dispensing step
resulted in a rapid (,2 s) drop in fluorescein concentration
followed by a gradual (,8 s) increase to a new level, which was
significantly lower than the original concentration. The rapid drop
was caused by convective flow through the microwell that
propelled non-fluorescent buffer into the microwell. The convec-
tive flow was readily observable using tracer particles, but was too
weak to move C. elegans embryos. The subsequent gradual increase
of the concentration was likely due to diffusive mixing of the
relatively concentrated fluorescein solution remaining in the well
after the aspiration step. (The diffusion time h
2/(2D), with
h=150 mm, is ,25 seconds and thus comparable with the time
scale of the gradual concentration decrease). It is worth noting that
since the medium exchange is mostly driven by convection rather
than diffusion, the exchange time is not expected to be
substantially greater for macromolecular compounds with moder-
ate molecular weights.
Most importantly, after each of the medium exchange
(aspiration/dispensing) steps, the concentration in the microwell
rapidly decreased to ,42% (on average) of its pre-exchange value.
(The individual medium exchange steps are similar, when viewed
in the semi-logarithmic coordinates, but not identical because the
procedure is manual and thus not perfectly reproducible). So, the
fluorescein concentration decreased to ,3% of its initial value
(97% exchange) after 4 aspiration/dispensing steps (,55 seconds)
and to 1.3% (98.7% exchange) after 5 steps (,70 seconds).
Therefore, the data in figure S3B indicates that in addition to drug
addition the near complete removal of a substance from the
medium in the well can also be achieved by repeated aspiration/
dispensing within a ,1–2 min time frame.
Supporting Information
Figure S1 Optimization of perm-1 RNAi by soaking.
After generating a new batch of perm-1 dsRNA or when using a
new worm strain, soaking RNAi conditions were optimized using
this protocol.
(EPS)
Figure S2 Eggshell permeabilization using feeding
RNAi. A. Optimization of perm-1 RNAi by feeding. When using
a new worm strain, feeding RNAi conditions were optimized using
this protocol. B. Graph showing the percent of embryos that were
permeable (green bars) and that exhibited polar body resorption
defects (red bars) after L4 or young adult worms were fed
bacteria expressing perm-1 dsRNA for the indicated time intervals.
(EPS)
Figure S3 The microdevice. A. Schematicdrawings of the top
view and cross-sectional view of the microdevice as well as the
microwells. B. Concentration of fluorescein (in semi-logarithmic
scale) in a 3006300 mm microwell normalized to its initial
concentration (60 ppm) as a function of time during a medium
exchange procedure composed of 5 consecutive steps of aspiration
of the existing medium from the 668 mm well and dispensing of
plain buffer into the well (at time points of about 5, 21, 40, 58, and
72 seconds). The small molecule concentration in the microwells
reaches equilibrium ,5 s after medium replacement. A single cycle
of aspiration/dispensing leads to an equilibrium small molecule
concentration in the well that is ,60% of that in the added buffer.
(EPS)
Movie S1 Images of control and nocodazole-treated
permeable embryos expressing GFP-histone H2B and
GFP-alpha-tubulin. A control embryo (left) and an embryo in
which the media was replaced with media containing 10 mg/ml
nocodazole just after nuclear envelope breakdown (right) are
shown. Nocodazole addition results in rapid microtubule depoly-
merization and a decrease in the distance between the spindle
poles. The chromosomes do not align in a metaphase plate and the
embryo does not proceed into anaphase. Images are projections of
5 confocal sections, 2 mm apart, acquired every 20 seconds.
Playback rate is 406real time.
(MOV)
Movie S2 Images of a permeable embryo expressing
GFP-histone H2B and GFP-alpha-tubulin treated with
nocodazole during pronuclear migration. Addition of
10 mg/ml nocodazole prevents the pronuclei from moving towards
each other but does not prevent chromosome condensation and
nuclear envelope breakdown. Images are projections of 5 confocal
sections, 2 mm apart, acquired every 20 seconds. Playback rate is
406real time.
(MOV)
Movie S3 Images of a permeable embryo expressing
GFP-histone H2B and GFP-alpha-tubulin treated with
nocodazole during anaphase. Addition of 10 mg/ml nocoda-
zole just after anaphase onset results in rapid microtubule
depolymerization and failure of cytokinesis. Images are projections
of 5 confocal sections, 2 mm apart, acquired every 20 seconds.
Playback rate is 406real time.
(MOV)
Movie S4 Embryos co-expressing a GFP-labeled plasma
membrane probe (green) and mCherry-labeled histone
H2B (red) undergoing the first mitotic division in the
absence (left) or in the presence of 10 mM Latrunculin A
(right). Addition of latrunculin A during anaphase results in
failure of cytokinesis but does not block nuclear division.
Latrunculin A addition also results in the accumulation of the
plasma membrane probe in the cytoplasm (in the region of the
spindle poles) upon DNA decondensation. Images are projections
of 5 confocal sections, 2 mm apart, acquired every 20 seconds.
Playback rate is 406real time.
(MOV)
Movie S5 Images of permeable embryos expressing
GFP-histone H2B and GFP-alpha-tubulin undergoing the
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a proteosome inhibitor, c-lactocystin-ß-lactone (right).
Addition of 20 mM c-lactocystin-ß-lactone early, during ana-
phase of meiosis II, leads to arrest at metaphase of the first
mitotic division. Images are projections of 5 confocal sections,
2 mm apart, acquired every 20 seconds. The playback rate is
406 real time.
(MOV)
Movie S6 Images of permeable embryos expressing
GFP-histone H2B and GFP-alpha-tubulin undergoing the
first and second mitotic divisions in the absence (left)o r
presence of a proteosome inhibitor, c-lactocystin-ß-
lactone (right). Addition of 20 mM c-lactocystin-ß-lactone
before NEBD delayed the metaphase-anaphase transition but
the embryo did not arrest until metaphase of the second mitotic
division. Images are projections of 5 confocal sections, 2 mm
apart, acquired every 20 seconds. Playback rate is 406 real
time.
(MOV)
Spreadsheet S1 Excel sheet summarizing the results of
the eggshell permeability screen.
(XLSX)
Table S1 Strains used in this study.
(DOCX)
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